Open AccessLong-term response to recombinant human growth hormone therapy in Indian children with growth hormone deficiency
Author(s) -
Monita Gahlot,
Alpesh Goyal,
Arun Kumar Singh,
Viveka P Jyotsna,
Nidhi Gupta,
Rajesh Khadgawat
Publication year - 2019
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/ijem.ijem_300_19
Subject(s) - medicine , growth hormone deficiency , context (archaeology) , anthropometry , human growth hormone , pediatrics , growth hormone , bone age , retrospective cohort study , endocrinology , hormone , paleontology , biology
Growth hormone deficiency (GHD) remains the most common indication for use of recombinant human growth hormone (rhGH) therapy in clinical practice. However, there is a paucity of studies focusing on long-term response to rhGH therapy in the Indian context.